Stay updated on Biomarker-Based AML Treatment Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Based AML Treatment Clinical Trial page.

Latest updates to the Biomarker-Based AML Treatment Clinical Trial page
- ChecktodayChange DetectedThe site footer now identifies the ClinicalTrials.gov platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.6%

- Check28 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check49 days agoChange DetectedThe label 'Find contact information' on the history page is re-capitalized. A new revision tag shows Revision: v3.7.0, replacing the previous v3.6.6 and signaling an updated study record version.SummaryDifference0.2%

- Check56 days agoChange DetectedNew sections were added to the record history, including References, Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Sponsor/Collaborators, and Study Status. These additions broaden the documented content of the study record.SummaryDifference1%

- Check63 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the record history, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Biomarker-Based AML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Based AML Treatment Clinical Trial page.